Introduction
The prostate is a sex-accessory exosecretory gland in mammalian males. Prostate gland develops by branching morphogenesis from the epithelium and mesenchyme of the urogenital sinus (UGS), an enlarged portion of the urethra beneath the bladder. Adult prostate is composed of branched ducts, made of stratified epithelium, separated by the basal lamina from the fibroblast stroma and smooth muscle envelope. The luminal layer of prostate epithelium is characterized by expression of specific intermediate filaments, cytokeratin 8 (CK8) and CK18, contains secretory cells, and is androgen-dependent for cell survival and terminal differentiation (Marker et al., 2003; Wu et al., 2007) . In turn, cells in the basal epithelial layer are characterized by expression of CK5 and CK14 (Marker et al., 2003) . In addition, the basal epithelium contains rare neuroendocrine cells, expressing neural peptides, such as secretagogin, chromogranin, calcitonin gene-relater peptide and synaptophasin (Abate-Shen and Shen, 2000; Marker et al., 2003) .
The prostate retains the ability to support cell replication, differentiation and morphogenesis throughout adult life, which suggests an abundance of pluripotent stem cells. Abnormal proliferation and transformation of the prostate stem and progenitor cells results in benign prostate hyperplasia and prostate cancers (Abate-Shen and Shen, 2000; Marker et al., 2003) . Recent studies indicate that prostate gland contains at least two different stem cell niches, a "normal" stem cell" niche in the basal compartment Xin et al., 2003) , and another niche with a capability to generate "cancer stem cells" in the luminal compartment . Notably, regulation of cell fate choice in both normal and cancer prostate stem cells is susceptible to the evolutionary conserved Notch cell fate selection system (Artavanis-Tsakonas et al., 1999; Shahi et al., 2011; Yoon and Gaiano, 2005) .
Recent studies by us and others underlined the importance of the Notch1 receptor and Notch ligands, Delta-like1, Jagged1 and Jagged 2, in prostate branching (Grishina et al., 2005; Wang et al., 2004) and epithelial differentiation (Wang et al., 2006) . Other studies indicated a role for the Notch2 receptor and Delta-like1 ligand in survival and differentiation of the prostate stroma (Orr et al., 2009) . Activation of the Notch receptor results in a γ-secretase dependent proteolytic cleavage of the Notch intracellular domain (NIC) and its nuclear translocation (Fig. 1) . In the nucleus, NIC forms a transcription complex with its DNAbinding co-factor, RBP-J/Supressor of Hairless/Lag-1/CBF-1, and promotes expression of the Hes/Hey/Herp transcriptional repressors (ArtavanisTsakonas et al., 1999; Belandia et al., 2005; Ohtsuka et al., 1999; Tanigaki et al., 2002; Yoon and Gaiano, 2005) . In the absence of Notch signaling, RBP-J forms a complex with transcriptional repressors and prevents opportunistic expression of the Notch target genes (Zhou and Hayward, 2001) . The Notch targets, the Hes/Hey/Herp factors, have been shown to repress transcription of the proneural basic helix-loop-helix transcription factors, Mash1, Math1 and Ngn3, which function to promote neural differentiation in the neural tube and forebrain (Yoon and Gaiano, 2005) , as well as secretory differentiation in the pancreas and intestine (Fre et al., 2005; Murtaugh et al., 2003; Stanger et al., 2005; Yang et al., 2001) . Their role in neuroendocrine differentiation in the lungs has been also suggested (Ito et al., 2000) . Our studies and studies of other laboratories indicate that during prostate development, Notch signaling is mediated primarily by Hes1 and Hey1 (Belandia et al., 2005; Grishina et al., 2005; Wang et al., 2004) . Hey1 has been shown to function as a corepressor of the androgen receptor targets, indicating that inhibition of Notch signaling may be required for differentiation of the prostate secretory epithelium (Belandia et al., 2005; Wu et al., 2007) .
Importantly, abnormal regulation of the Notch pathway has been suggested to contribute to benign prostate tumors (Belandia et al., 2005) , and may play a role in predisposition to prostate cancer (Whelan et al., 2009) . In particular, studies indicate that signaling by the Notch receptor can affect proliferation and cell fate choice in prostate, and other, cancer cell lines by regulating transcription of the phosphatase and tensin homolog gene (PTEN) (Palomero et al., 2007; Salmena et al., 2008; Whelan et al., 2009) . PTEN is a lipid and protein phosphatase, and a potent tumor suppressor which functions by antagonizing the phosphoinositide 3-kinase (PI3K)/Akt cell survival pathway. Notably, studies in cell lines pointed that Notch can regulate PTEN both positively and negatively depending on cellular context (Palomero et al., 2007; Salmena et al., 2008; Whelan et al., 2009 ). These findings make it particularly important to define the interactions between the Notch and PTEN/Akt pathways during normal prostate development, and during the initial stages of benign and malignant prostate tumors.
In this study, we employed three prostate-specific Cre/LoxP systems to investigate the effects of gain and loss of Notch signaling in mouse models, during prostate formation in embryogenesis and during postnatal differentiation of the organ. We used the prostate-specific, Nkx3.1
Cre and Probasin(PB) Cre4 drivers to express Cre recombinase in the embryonic and postnatal prostate. Nkx3.1 is a prostate specific homeobox gene which is expressed in the prostate epithelium from the earliest stages of prostate budding at the embryonic (E) day E15.5 (Bhatia-Gaur et al., 1999) . PB Cre4 drives Cre expression in the prostate epithelium and smooth muscle, postnatally, under a modified promoter for a rat prostate secretory protein (Wu et al., 2001) . To investigate the effects of gain of Notch function, we used the conditional strain, Rosa Notch1IC (Rosa
N1IC
) (Murtaugh et al., 2003) , carrying the constitutively active intracellular domain of the Notch1 receptor, N1IC. To investigate the effect of loss of Notch signaling, we used a floxed allele for the ubiquitous transcriptional mediator of Notch signaling, RBP-J flox (Tanigaki et al., 2002) . Our study uncovered intriguing similarities in Notch function in the prostate epithelium and adjacent stroma. We found that gain of Notch function during prostate development resulted in Fig. 1 . The Notch pathway. Notch signaling between adjacent cells functions to diversify cell fate: selecting progenitor cells which will maintain pluripotency, and cells which will terminally differentiate. In mammals, signaling by the Notch 1-4 transmembrane receptors is activated by binding to the Delta-like1-4 and Jagged1,2 ligands, themselves transmembrane receptors on neighboring cells. Ligand-receptor binding promotes a series of cleavages, first, by the intracellular γ-secretase complex, to produce the Notch intracellular domain (NIC), then, by the ADAM metalloproteinase to remove the extracellular domain. Cleaved NIC translocates to the nucleus where it functions as a transcription factor together with its DNA-binding co-factor, RBP-J/Suppressor of Hairless/Lag-1/CBF-1. In the absence of Notch signaling RBP-J remains bound to the consensus sites and functions as a repressor for Notch target genes. NIC induces expression of the Hes/Hey/Herp family of transcriptional repressors which in turn suppress transcription of the patterning basicloop-helix (bHLH) transcription factors, Mash1, Math1 and Neurogenin. In the prostate, Hey1 functions as a co-factor for the androgen receptor (AR) to repress AR targets.
inhibition of PTEN, activation of the Akt cell survival pathway, and increased proliferation of the basal and myoblast progenitors leading to an early onset of benign prostate hyperplasia by three months of age. In turn, loss of Notch signaling resulted in upregulation of PTEN, loss of basal and myoblast progenitors, and abnormal cell differentiation in both epithelial and stromal compartments. Our studies point to the importance of precise regulation of Notch signaling during prostate development, and the role of Notch in the homeostasis of the adult organ.
Materials and methods

Mouse lines and X-gal staining
All mouse studies were conducted in accordance with an animal protocol approved by the New York University School of Medicine Institutional Animal Care and Use Committee. All mouse strains were maintained in C3H/HeJ background (Taconic, NY) unless otherwise indicated. Nkx3.1
Cre strain is a gift from M. Shen (Columbia University).
The Cre sequence is a knock-in resulting in a loss of Nkx3.1 function (Wang et al., 2006) . Genotyping for the Nkx3.1 Cre allele was carried out by PCR with a forward, Cre-F: GCG CGG TCT GGC AGT AAA AAC, and a reverse Cre-R: CAG ATG GCG CGG CAA CAC C, primers, under the following conditions: 94°C, 5 min; 38 cycles of 94°C for 15 s, 58°C for 30 s, 72°C for 1 min; then 72°C for 10 min. PB Cre4 is a transgenic strain which drives expression of Cre-recombinase in the postnatal prostate epithelium and in smooth muscle (Wu et al., 2001) . Rosa26 is a Crereporter strain which carries a LacZ gene preceded by stop codon flanked by LoxP sites (Soriano, 1999) . RBP-J flox (Tanigaki et al., 2002 ) is a conditional loss of function allele of RBP-J, a ubiquitous transcriptional mediator of canonical Notch signaling. RBP-J flox strain is maintained as homozygous in mixed SW/Bl6 background. Rosa N1IC (Murtaugh et al., 2003 ) is a conditional transgene, containing a sequence for the Notch1 intracellular domain, N1IC. Embryonic (E) day 0.5 (E0.5) was designated as the day when vaginal plug was first observed, and day of birth was marked as postnatal (P) day 1 (P1). Sex of embryos, starting from E15.5, was determined by the characteristic positions of the sexually committed gonads. X-gal staining of the Nkx3.1
Cre/+ ;Rosa26 and PB Cre4/+ ;Rosa26 tissues has been performed as described previously (Grishina et al., 2005; Wu et al., 2009 ).
Tissue collection and immunofluorescent analysis
Urogenital sinuses including prostate tissues were dissected from male mice and embryos using Zeiss Stemi SV11 dissection microscope, rinsed in ice cold PBS and fixed in 4% paraformaldehyde for 1 h, dehydrated and embedded in paraffin, and sectioned at 5 μm. For immunofluorescent labeling, sections were processed as described previously (Grishina et al., 2005) , and incubated with primary antibodies overnight at 4°C in the Tyromide Signal Amplification (TSA, Invitrogen, Carlsbad, CA) or Mouse On Mouse (Vector Laboratories, Burlingame, CA) blocking solutions, followed by incubation with Alexa Fluor secondary antibodies (Invitrogen, Carlsbad, CA), or processed with the TSA kit #23 kit (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. Primary antibodies for Ki-67 (catalogue number 15580, Abcam, Cambridge, MA) and phospho-Histone H3 (pHH3) (catalogue number 6570, Upstate Biotechnology, Billerica, MA) were used at 1:100 dilution, and antibodies for smooth muscle α-actin (α-sma) (Clone 1A4, DAKO, Glostrup, Denmark) and myosin (BT-562, BTI, Stoughton, MA) were used at 1:100 dilution, followed by Alexa Fluor secondary antibodies. Primary antibodies for PTEN (catalogue number 9559, Cell Signaling, Danvers, MA) and N1IC (catalogue number 2421, Cell Signaling, Danvers, MA) were used at 1:100 dilution, and antibodies for CK8 (catalogue number 14053, Abcam, Cambridge, MA), CK14 (catalogue number PRB-155P, Covance, Princeton, NJ), Bcl-2 (catalogue number 18210, Abcam, Cambridge, MA), p63 (catalogue number 3239, Abcam, Cambridge, MA), and phospho-Akt (pAkt) (catalogue number 4060, Cell Signaling, Danvers, MA) were used at 1:50 dilution with the Tyromide Signal Amplification kit # 23 (Invitrogen, Carlsbad, CA) as described (Grishina et al., 2005) . Fluorescent imaging was performed using Zeiss Axioplan3.1 fluorescent microscope at the Urology Research Laboratories, and the LSW 510 confocal scope at the New York University School of Medicine Microscopy Core Facility.
Analysis of programmed cell death
Programmed cell death was evaluated on tissue sections by terminal deoxynucleotidyl transferase dUTP nick end labeling reaction (TUNEL) following the manufacturer's instructions (Roche Applied Science, Indianapolis, IN).
Quantitations and statistics
In embryonic tissues, calculations of the percentage ratios for the cells positive for TUNEL and immunohistochemical markers were carried out in comparison to the total cell number in the particular epithelial or stromal compartment identified by 4′,6-diamidino-2-phenylindole (DAPI) staining of the nuclei. Cell counts were performed on twenty tissue sections, five each from five non-littermate embryos of each genotype, unless otherwise indicated. In the postnatal prostate, cell counts for specific markers were carried out in five 10 6 μm 2 quadrants on each of twenty sections from five non-littermate animals of each genotype, unless otherwise indicated. Measurements and cell counts were performed using Axiovision 2 (Carl Zeiss MicroImaging, Thornwood, NY) and Volocity 5.3.1 Software (Perkin Elmer, Waltham, MA). Statistical significance of the calculations was determined by the Student's t-test. P b 0.05 was considered significant.
Results
Nkx3.1
Cre is expressed in epithelial and mesenchymal prostate cells Nkx3.1 is a prostate-specific homeobox gene and tumor-suppressor (Bhatia-Gaur et al., 1999; Kim et al., 2002; Abate-Shen et al., 2003) . In embryogenesis, transient Nkx3.1 expression has been also reported in the lungs, somites, duodenum and elements of the skeleton (Stanfel et al., 2006) . First, we determined the domains of Cre recombinase expression in our Nkx3.1
Cre strain (gift of M. Shen, Columbia).
Cre/+ males were mated with the Rosa26 females (Soriano, 1999) , and the resulting Nkx3.1
Cre/+ ;Rosa26 embryos and postnatal prostates were analyzed for expression of the LacZ reporter (Fig. 2) . LacZ expression was first detected in the UGS epithelium at E16.5 (Fig. 2F,  arrow) , and at E17.5, in the emerging buds of the prostate (Figs. 2B and H) and bulbourethral glands (Fig. 2B) . In embryogenesis, LacZ expression was also present in a few cells in the periepithelial mesenchyme in between the urethra and smooth muscle (* in ; Rosa26 embryos show LacZ expression in the axial mesoderm (Figs. 2O-Q, and S), similar as described for an independently made Nkx3.1
Cre strain (Stanfel et al., 2006) . This is consistent with a transient expression of Nkx3.1 in the developing somites (Kos et al., 1998) . In our experiments, ectopic activation of Notch1 signaling in the sclerotome in the Nkx3.1
Cre/+ ;Rosa N1IC/+ embryos resulted in lethality at birth due to incomplete closure of the neural tube (Fig. 2R) . Thus, to analyze the effect of gain of Notch function in the postnatal prostate (Figs. 4-5), we employed the PB Cre4 strain, which has been reported to drive expression of Cre in the prostate epithelium and smooth muscle, postnatally (Wu et al., 2001) . PB 
Gain of Notch function in embryonic prostates results in increased cell proliferation and survival
To determine the effect of gain of Notch function during the initial stages of prostate formation and outgrowth of the primary buds, UGS sections were obtained from Nkx3. In wild-type E17.5 ( Fig. 3A ) and E18.5 UGS (Fig. 3N ), endogenous Notch1 activity was detected in the UGS epithelium, in the forming prostate buds (Figs. 3A and N) , and in a few cells in the urogenital mesenchyme (arrows in insets in Figs. 3A and N) . Our previous studies (Grishina et al., 2005 ) also showed endogenous Notch1 activity, and expression of Hes1, Gain of Notch function in the embryonic prostate results in downregulation of PTEN, and increase in phosphorylation of Akt PTEN is a lipid and protein phosphatase, which functions as a tumor suppressor by antagonizing the PI3K/Akt cell survival pathway and inhibiting the cell divisions cycle (Salmena et al., 2008) . Thus, we asked whether Notch signaling functions to favor cell survival and proliferation by limiting levels of PTEN. We detected significant levels of PTEN protein in the normal E18.5 UGS epithelium and adjacent mesenchyme (Fig. 3O) . In contrast, in E18. Several studies indicate that transcription factor p63 marks a basal prostate cell population enriched for stem and progenitor cells (Shahi et al., 2011; Signoretti et al., 2005; Xin et al., 2007) . We found that gain of Notch function in embryonic prostate resulted in higher rates of cell divisions in the basal UGS epithelium (Figs. 3H and B, and I and C) . Thus, we asked whether this increase in cell proliferation would specifically ;Rosa26 reporter system (Wu et al., 2001) showed LacZ expression in all prostate lobes from P1 to 8 weeks of age. Wu et al. (2001) also performed histological analysis of X-gal stained prostate sections to show Cre expression in the periductal smooth muscle (Wu et al., 2001 ). Our analysis of sections of P14 PB Cre4/+ ;Rosa26 ventral prostates, X-gal stained and immunolabeled for α-sma, confirmed LacZ expression in the prostate epithelium and in adjacent smooth muscle (Fig. 4A) . Further examination of the PB Cre4/+ ;Rosa N1IC/+ ventral prostates showed a significant increase in the N1IC signal in the ductal epithelium (Figs. 4H and B) , prostate buds (arrowhead in Fig. 4H ), and smooth muscle (arrows in Fig. 4H , and in Supplemental Material Figs. S1E and F). We further examined whether gain of Notch function affected cell fate choice in the epithelium or stroma. We first examined whether gain of Notch function in postnatal prostates resulted in increased cell proliferation. We labeled twenty prostate sections from P14 PB (Fig. 4N ). Similar increase in the rates of cell proliferation was observed in the anterior, dorsal and lateral lobes (data not shown).
Gain of Notch function results in increase in the basal and smooth muscle progenitor cells in the postnatal prostate
To determine whether gain of Notch activity in the postnatal prostate affects the p63 + cell population we performed immunolabeling of prostate sections from P7 PB , UGS sections at E17.5 and P1 were labeled for Ki-67 (A and E, and B and F), and processed for TUNEL assay (C, G). ducts were surrounded by an abnormally thick layer of smooth muscle (Figs. 4L and M, compare to F and G). Wild-type P14 ventral ducts have a 1.6-2.0 layers of smooth muscle (Fig. 4N) . In contrast, P14 PB Cre4/+ ; Rosa N1IC/+ ducts had 2.9-3.1 (Pb 0.01) layers of smooth muscle cells (Fig. 4N) . Moreover, PB Cre4/+ ;Rosa N1IC/+ smooth muscle envelopes were on average 60% thicker than in the control prostates (Figs. 4N , and G compare to M). Measurements conducted using Axioplan 2 (Carl Zeiss MicroImaging) software showed that control P14 ventral ducts were surrounded by 3.0-4.5 μm of smooth muscle (Figs. 4N, ;Rosa N1IC/+ myoblasts also showed a looser arrangement of the actin filaments (Fig. 4M ) compared to the tightly packed actin bundles in wild-type smooth muscle (Fig. 4G) . Thus, gain of Notch function resulted in a delay in myoblasts to myocyte differentiation. In summary, our studies show that gain of Notch function in the postnatal prostate results in increase in progenitor cells in the basal and smooth muscle compartments.
Gain of Notch function results in an early onset of prostate hyperplasia
We next asked whether gain of Notch activity in postnatal prostates may lead to pathological conditions, such as benign hyperplasia or intraepithelial neoplasia, in the adult. To examine the effect of gain of Notch function on cell differentiation and tissue integrity in the adult gland, we obtained prostate tissues from six three month old PB Cre4/+ ;Rosa N1IC/+ and control males, and analyzed tissue histology and differentiation of the epithelium and smooth muscle in all prostate lobes (Fig. 5 , ventral prostate is shown). Control prostates showed normal histology and accumulation of prostate secretions in the lumen (Fig. 5A, * ; Rosa N1IC/+ prostates also contained numerous fibro-muscular nodules in the stroma (Fig. 5G, arrow) . These stromal conditions are also typical for benign prostate hyperplasia in men. PB Cre4/+ ;Rosa N1IC/+ ventral ( Fig. 5 ) and lateral prostate lobes (not shown) showed essentially identical characteristics of benign prostate hyperplasia in the organization of the epithelial and stromal compartments. The anterior and dorsal lobes showed similar levels of excess basal and myoblast cell proliferation, but less extensive cell proliferation in the luminal compartment, and retained secretory activity (not shown). In summary, our results show that gain of Notch function in postnatal prostates resulted in an early onset of benign prostate hyperplasia by 
Loss of Notch/RBP-J function results in decreased cell proliferation and survival
To investigate the effect of loss of Notch signaling during prostate development, we employed the Nkx3.1
Cre/+ ;RBP-J flox/flox bigenic system, where the ubiquitous transcriptional mediator of Notch, RBP-J , is inactivated in the epithelial and mesenchymal prostate cells where Nkx3.1 is expressed ( Fig. 2 and Supplemental Material Fig. S1 ). Nkx3.1 Cre/+ ;RBP-J flox/flox males showed no apparent morphological abnormalities, developed to adulthood, and were fertile. , littermates were labeled for Ki-67, and Ki-67 + cells quantified separately in the UGS epithelium (Fig. 6D, ep) and within 25 μm of the periepithelial mesenchyme (Fig. 6D, pm) . We found that loss of Notch/RBP-J function resulted in lower levels of cell proliferation in embryonic and P1 UGS epithelium and mesenchyme (Figs. 6D, and A compare to E, and B compare to F). At E17.5, Nkx3.1
Cre/+ ;RBP-J flox/flox UGS epithelium showed 14.6% (P b 0.01) fewer cycling cells than control tissue (Figs. 6D, and A, E) . At P1, 15.6% (Pb 0.01) fewer dividing cells were found in the mutant prostate tips compared to controls (Figs. 6D, and B, F) . In the Nkx3.1
Cre/+ ; RBP-J flox/flox periepithelial mesenchyme, cell proliferation was 6.5%
(Pb 0.01) lower at E17.5 (Figs. 6D, and A, E), and 6.2% (Pb 0.05) lower at P1 (Figs. 6D, and B, F) . We then determined whether loss of RBP-J resulted in altered cell survival by carrying out TUNEL analysis at P1 (Figs. 6C, G , and H). We found that loss of Notch/RBP-J function resulted in a significant decrease in cell survival in the UGS epithelium. Specifically, Nkx3.1 Cre/+ ;RBP-J flox/flox P1 prostates contained 30% (Pb 0.01) more apoptotic nuclei in the UGS epithelium than control tissues (Figs. 6H, and C, G) .
Loss of RBP-J resulted in defects in stratification in the UGS epithelium
Histological analysis of prostate sections at P1 showed no significant difference in the number of the initial prostate buds in the Nkx3.1
Cre/+ ;RBP-J flox/flox and control prostates (Figs. 7A, C and E, G).
Thus, Notch/RBP-J function is not required for specification of the prostate lobes. However, we found severe defects in organization of the Nkx3.1
Cre/+ ;RBP-J flox/flox UGS epithelium (Fig. 7) . Normally, at the embryonic and early postnatal stages, urethral epithelium is multilayered and pseudostratified (Marker et al., 2003) . This was confirmed by histological analysis (Figs. 7A-B) , and labeling of the wild-type P1 UGS for CK14 (Figs. 7C and D) . In contrast, Nkx3.1 Cre/+ ;RBP-J flox/flox UGS epithelium consisted of a single layer of cuboidally shaped cells (Fig. 7H ). Nkx3.1 Cre/+ ;RBP-J flox/flox UGS epithelium also showed significant shedding of cells into the lumen (Figs. 7E and F arrowheads) consistent with increased levels of cell death (Figs. 6G and H) . This data indicates that loss of Notch/RBP-J function resulted in significant defects in differentiation and organization of the UGS epithelium.
Loss of Notch/RBP-J function results in increased levels of PTEN, and defects in maintenance of the basal and myoblast progenitors
We further determined whether loss of RBP-J affected maintenance of epithelial and smooth muscle progenitors in the postnatal prostate. Immunolabeling for p63 showed that Nkx3.1 ;RBP-J flox/flox prostates also showed significantly reduced epithelial secretions in all prostate lobes (Fig. 10 , and data not shown). These findings are consistent with defects in epithelial differentiation in cNotch1 null prostates (Wang et al., 2006) . In the normal differentiated prostate ducts, CK14 is expressed in the basal epithelium, and is absent from the luminal compartment ( Figs ducts contained large CK14 + cells that extended towards the lumen (Fig. 11F) . Thus, loss of Notch/RBP-J function in the developing prostate resulted in defects in specification of the basal and luminal prostate epithelium, and the smooth muscle cells.
Discussion
We and other laboratories have shown the importance of the Notch cell fate selection system in regulating prostate growth, regeneration and epithelial differentiation (Grishina et al., 2005; Wang et al., 2004 Wang et al., , 2006 . Notch signaling is also required for the maintenance of epithelial progenitors in the pancreas, intestine and mammary gland (Buono et al., 2006; Fre et al., 2005; Murtaugh et al., 2003; Stanger et al., 2005) . In this study, we employed conditional murine models to systematically investigate the role of Notch signaling in development of the prostate epithelium and stroma.
Our analysis of gain and loss of Notch function indicates that during normal development, Notch signaling inhibits accumulation of the tumor suppressor PTEN in the UGS and prostate epithelium, and in the adjacent stroma. Notch-dependent inhibition of PTEN has been reported to regulate cell survival and proliferation in T-cell leukemias (Palomero et al., 2007) . In contrast, Notch has been suggested to upregulate PTEN in Du145 and 22Rv1 prostate cancer cell lines (Whelan et al., 2009) . Our studies in conditional murine models strongly indicate that during normal prostate development Notch signaling inhibits accumulation of PTEN, and supports maintenance of the patterned progenitor cells in the epithelial and smooth muscle compartments. We show that gain of Notch function in the embryonic prostates results in a significant decrease in the levels of PTEN, and increase in the active phosphorylated form of Akt, and its target, Bcl2, both in the prostate epithelium and mesenchyme. Consistent with the effects of gain of Notch function, loss of Notch/RBP-J resulted in upregulation of PTEN, and decreased rates of cell division and survival in the prostate epithelium and smooth muscle.
Next, our findings strongly indicate a positive role for Notch signaling in maintenance of the p63 + basal progenitors (Kurita et al., 2004; Robinson et al., 1998; Signoretti et al., 2005; Wang et al., 2001) . Gain of Notch function resulted in formation and maintenance of a 50% larger population of basal progenitors in the urogenital sinus. Gain of Notch function also resulted in a higher rates of epithelial cell divisions throughout development, and an increased mass of basal and luminal epithelial cells in the adult prostates. This resulted in the early onset of prostate hyperplasia at three months of age manifested in increased mass of the basal and luminal epithelium. Interestingly, our results indicate that gain of Notch signaling does not prevent specification of the luminal epithelium. Gain of Notch activity also resulted in hyperproliferation of the patterned smooth muscle progenitor cells, the α-actin-positive myoblasts. As a result, PB Cre4/+ ;Rosa N1IC/+ prostates form abnormally thick smooth muscle envelopes and develop fibromuscular nodules in the glandular stroma. These epithelial and stromal pathologies are consistent with benign prostate hyperplasia in men (Lee and Peehl, 2004) , and in murine models (Kim et al., 2002) . Consistent with the effects of gain of Notch function, loss of Notch/ RBP-J resulted in upregulation of PTEN, decreased rates of cell division and survival in the prostate epithelium, and a rapid loss of basal prostate progenitors, postnatally. Loss of Notch function also resulted in defects in differentiation of the basal and luminal epithelium. Previous studies employed pharmacological γ-secretase inhibitors, and performed a conditional deletion of the Notch1 receptor in the postnatal prostate, to show the importance of Notch signaling for compartmentalization and secretory differentiation of the prostate epithelium (Wang et al., 2006) . Our studies show that loss of Notch function resulted in a significant decrease in cell survival and proliferation, as well as severe defects in epithelial differentiation in the embryonic, postnatal and adult prostate. Embryonic and newborn UGS epithelium is normally multilayered and pseudostratified. In contrast, loss of Notch signaling manifested in a severe reduction of the UGS epithelium to a single layer of cuboidal cells at the basal membrane. Defects in epithelial differentiation also manifested in the prostate ducts. Normal differentiated prostate ducts contain small elongated basal cells stretched along the lamina, and a single layer of luminal epithelium. Loss of Notch signaling resulted in severe defects in compartmentalization of the basal and luminal epithelial layers. As result, Nkx3.1
Cre/+ ;RBP-J flox/flox ducts contained abnormally large CK14 + basal cells which extended into the luminal compartment, and co-expressed the luminal marker, CK8. In summary, our studies show that Notch signaling controls survival and proliferation of the pluripotent basal progenitors, and that precise level of Notch signaling is necessary for specification of the basal and luminal lineages. Our studies also strongly indicate the importance of Notch signaling for maintenance and differentiation of smooth muscle progenitors. Gain of Notch function resulted in increased proliferation of myoblast progenitors, a delay in terminal differentiation, and formation of an additional 3rd layer of smooth muscle in the adult gland. Persistent Notch signaling also caused a delay in condensation of smooth muscle. At P14, adolescent prostates were surrounded by thick but loosely packed smooth muscle envelopes, which retained partially-differentiated myoblasts. Consistently, loss of Notch function manifested in loss of myoblasts, and abnormally thin and discontinuous smooth muscle envelopes. (Hayward et al., 1996) . This is a strong evidence that Notch signaling is necessary for maintenance and differentiation of the smooth muscle lineage. The role for Notch in differentiation of the smooth muscle is a relatively novel concept. However, recent report pointed to the significance of the Notch2 signaling in differentiation and survival of the prostate stroma (Orr et al., 2009) . Other studies implicated Notch1 in differentiation and proliferation of the arterial smooth muscle (Feng et al., 2010; Tang et al., 2010; Morrow et al., 2010) . In addition, ectopic Notch1 signaling has been implicated in the pathological differentiation of myofibroblasts in pulmonary fibrosis (Liu et al., 2009) , and in osteogenic mineralization of vascular smooth muscle in arteosclerotic plaques (Shimizu et al., 2009 ; Rosa N1IC smooth muscle. Thus, we provide evidence that in our systems, Notch signaling is modulated cell-autonomously in the epithelium and stroma. Yet, considering the importance of signaling interactions between the epithelium and mesenchyme for prostate development and homeostasis, it is necessary to evaluate other signaling pathways which may contribute to the observed phenotypes. For instance, signaling by the epithelial Sonic hedgehog (Shh) (Podlasek et al., 1999) , Bone morphogenetic proteins 4 and 7 (Grishina et al., 2005; Lamm et al., 2001 ) and Wnt molecules (Huang et al., 2009; Ontiveros et al., 2008; Yu et al., 2009) can affect differentiation of the myoblast progenitors and formation of the periductal smooth muscle (Perez et al., 2011; Shaw et al., 2006 (Jerde et al., 2011; Ohigashi et al., 2005) . Our unpublished studies indicate that gain and loss of Notch signaling in the embryonic prostates do not affect the Bmp/phospho-Smad1/5/8 pathway. However, our previous studies show that Notch and Wnt pathways function in the same cell populations in the prostate epithelium and in the adjacent mesenchyme (Grishina et al., 2005; Wu et al., 2011) . We also found that gain of Notch function the embryonic prostates resulted in upregulation of Lef1, a mediator and reporter in the canonical Wnt pathway (Wu et al., 2011, and our unpublished data) . Other reports confirm the complex interactions between the Notch and Wnt pathways in maintenance of the progenitor cells and their niche (Buske et al., 2011; Radtke et al., 2006; Shahi et al., 2011) . Thus, further studies should clarify the roles and interactions between Notch and Wnt pathways in maintenance and differentiation of the prostate progenitor cells in the epithelial and stromal compartments. In the last decade, studies in multiple species and organs systems pointed to the importance of the Notch cell fate selection system in maintenance and proliferation of pluripotent progenitors, and the importance of timely inhibition of Notch signaling for differentiation of the secretory and neural lineages. Our analysis of the effects of gain and loss of Notch signaling during prostate development demonstrates the importance of fine regulation of Notch signaling for proper development of the prostate epithelium and smooth muscle. The peculiarity of prostate homeostasis is that prostate retains a high number of progenitor/stem cells in the adult tissue which allows for prostate regeneration, and also makes the gland vulnerable to the hormonal and developmental signals, such as by steroid hormones, and Notch and Wnt ligands. Importantly, our studies demonstrate that both loss and gain of Notch function have significant consequences for prostate differentiation and tissue integrity, and can lead to abnormal tissue homeostasis and predisposition to disease in the adult organ.
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